BIRC5 and cancer: Therefore, from a cancer prevention and therapeutics point of view, Survivin-2B, which is a proapoptotic protein [6], may act as a natural antagonist against the function of Survivin and/or Survivin-∆Ex3 leading to novel approaches for cancer prevention and/or therapeutics through differential modulation of the expression of Survivin and/or its variants.